Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Limited evidence for use of second-generation antipsychotics in anxiety disorders.

Frazier JA.

Evid Based Ment Health. 2011 Aug;14(3):76. doi: 10.1136/ebmh.14.3.76. No abstract available.

PMID:
21764875
[PubMed]
2.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Newcomer JW.

CNS Drugs. 2005;19 Suppl 1:1-93. Review.

PMID:
15998156
[PubMed - indexed for MEDLINE]
3.

[Antipsychotics].

Cattapan-Ludewig K, Seifritz E.

Ther Umsch. 2009 Jun;66(6):402-6. doi: 10.1024/0040-5930.66.6.402. German.

PMID:
19496035
[PubMed - indexed for MEDLINE]
4.

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.

Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K.

Br J Psychiatry. 2008 Jun;192(6):406-11. doi: 10.1192/bjp.bp.107.037184. Review.

PMID:
18515889
[PubMed - indexed for MEDLINE]
Free Article
5.

Tardive dyskinesia and new antipsychotics.

Correll CU, Schenk EM.

Curr Opin Psychiatry. 2008 Mar;21(2):151-6. doi: 10.1097/YCO.0b013e3282f53132. Review.

PMID:
18332662
[PubMed - indexed for MEDLINE]
6.

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM.

Am J Psychiatry. 2004 Mar;161(3):414-25. Review.

PMID:
14992963
[PubMed - indexed for MEDLINE]
7.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
8.

Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics.

Bond GR, Kim HW, Meyer PS, Gibson PJ, Tunis S, Evans JD, Lysaker P, McCoy ML, Dincin J, Xie H.

Psychiatr Serv. 2004 Jan;55(1):59-66.

PMID:
14699202
[PubMed - indexed for MEDLINE]
9.

Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Cohrs S.

CNS Drugs. 2008;22(11):939-62. Review.

PMID:
18840034
[PubMed - indexed for MEDLINE]
10.

Clinical trial-based cost-effectiveness analyses of antipsychotic use.

Polsky D, Doshi JA, Bauer MS, Glick HA.

Am J Psychiatry. 2006 Dec;163(12):2047-56. Review.

PMID:
17151153
[PubMed - indexed for MEDLINE]
11.

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

Kamble P, Sherer J, Chen H, Aparasu R.

Psychiatr Serv. 2010 Feb;61(2):130-6. doi: 10.1176/appi.ps.61.2.130.

PMID:
20123817
[PubMed - indexed for MEDLINE]
12.

Review of atypical antipsychotics in anxiety.

Vulink NC, Figee M, Denys D.

Eur Neuropsychopharmacol. 2011 Jun;21(6):429-49. doi: 10.1016/j.euroneuro.2010.12.007. Epub 2011 Feb 22. Review.

PMID:
21345655
[PubMed - indexed for MEDLINE]
13.

New generation vs. first generation antipsychotics debate: pragmatic clinical trials and practice-based evidence.

Jakovljević M.

Psychiatr Danub. 2009 Dec;21(4):446-52.

PMID:
19935477
[PubMed - indexed for MEDLINE]
Free Article
14.

Polypharmacy with second-generation antipsychotics: a review of evidence.

Pandurangi AK, Dalkilic A.

J Psychiatr Pract. 2008 Nov;14(6):345-67. doi: 10.1097/01.pra.0000341890.05383.45. Review.

PMID:
19057237
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J; CATIE Study Investigators.

Am J Psychiatry. 2006 Dec;163(12):2080-9.

PMID:
17151158
[PubMed - indexed for MEDLINE]
16.

A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.

Taylor D, Hayhurst K, Kerwin R.

Int Clin Psychopharmacol. 2007 May;22(3):133-6.

PMID:
17414738
[PubMed - indexed for MEDLINE]
17.

Are the second-generation antipsychotics cost-effective? A critical review on the background of different health systems.

Hamann J, Leucht S, Kissling W.

Pharmacopsychiatry. 2003 Jan;36(1):18-26. Review.

PMID:
12649770
[PubMed - indexed for MEDLINE]
18.

Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics.

Leitão-Azevedo CL, Guimarães LR, de Abreu MG, Gama CS, Lobato MI, Belmonte-de-Abreu PS.

Rev Bras Psiquiatr. 2006 Dec;28(4):301-4.

PMID:
17242810
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
[PubMed - indexed for MEDLINE]
20.

Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?

Motlová L, Spaniel F, Höschl C, Balon R.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):133-43. Review.

PMID:
17612853
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk